Entropy Technologies, LP Denali Therapeutics Inc. Transaction History
Entropy Technologies, LP
- $1.03 Trillion
- Q1 2025
A detailed history of Entropy Technologies, LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 11,215 shares of DNLI stock, worth $158,804. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,215Holding current value
$158,804% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
124MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$187 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$171 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$167 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$162 Million0.03% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$75.8 Million0.37% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.9B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...